Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT03906539

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03906539
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03906539. Randomized; double masking; primary purpose treatment. Start 2019-05-22 (actual); primary completion 2021-11-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia
Condition
Dyslipidemias
Intervention (Drug)
Atorvastatin 10mg
Intervention (Dietary supplement)
Virgin Coconut Oil (VCO)
Intervention (Other)
Placebo
Lead sponsor
All India Institute of Medical Sciences, Bhubaneswar (class: other)
Collaborator
Coconut Development Board, Government of India (class: not stated)

Record details

Record id
cardio:ct-nct03906539
Content hash
96524e73a2a8faba6ef4adf215b2438fa8db40d71950461c7c7e6cafa589e34c